Home › Research › Cognitive tests and assessment
Impact of anticoagulation on cognitive decline and clinical outcomes in patients with atrial fibrillation and dementia: A retrospective cohort study
Yun Du, Weng‐Chio Tam, Man-Fong Chu, Sio Mui Wong, Kuok Wun Lam, Tat-Kuong Tong, Mei-Hong Wong, Chon-Hou Chan et al.. Journal of Alzheimer s Disease Reports, 2026-03-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Background Atrial fibrillation (AF) and dementia frequently coexist in older adults, yet the impact of anticoagulation on cognitive and clinical outcomes in this population remains uncertain. Objective To evaluate the effects of anticoagulation on cognitive and clinical outcomes in patients with AF and dementia. Methods This retrospective cohort study included 291 patients aged ≥65 years with AF and dementia, treated at a tertiary center between January 2020 and December 2024. Patients were grouped by anticoagulation status. Cognitive, functional outcomes (Mini-Mental State Examination [MMSE], Activities of Daily Living [ADL], Clinical Dementia Rating–Sum of Boxes [CDR-SB]) and clinical endpoints (all-cause mortality, hospitalization, major adverse cardiovascular events, and bleeding) were assessed over a median 28-month follow-up. Results Anticoagulated patients were younger (82.8 versus 85.1 years, p = 0.01). Anticoagulation was associated with slower cognitive/functional decline, with medium effect sizes, ΔMMSE mean difference: 2.0 points (95% CI: −3.5 to −0.4; p = 0.048), ΔADL mean difference: 10.9 points (95% CI: −19.6 to −2.3; p = 0.02), ΔCDR-SB mean difference: −1.4 points (95% CI: 0.4 to 2.4; p < 0.01). In multivariable Cox models, anticoagulation reduced hospitalization risk (HR 0.60; 95% CI: 0.43–0.84; p < 0.01) and all-cause mortality (HR 0.59; 95% CI: 0.40–0.88; p = 0.01). Benefits were most pronounced in very mild dementia and Alzheimer's disease. Conclusions In this retrospective, confounder-adjusted study, anticoagulation was associated with slower cognitive/functional decline and lower hospitalization/mortality risk in AF and dementia patients. The findings warrant prospective research to investigate whether anticoagulation has disease-modifying effects in early-stage dementia.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 291 participants. In this retrospective study of 291 patients with atrial fibrillation and dementia, anticoagulation was associated with slower cognitive and functional decline and reduced hospitalization and mortality risk. Reported effect size: HR 0.60; HR 0.59.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Du, Y., Tam, W., Chu, M.-F., Wong, S. M., Lam, K. W., Tong, T.-K., et al. (2026). Impact of anticoagulation on cognitive decline and clinical outcomes in patients with atrial fibrillation and dementia: A retrospective cohort study. Journal of Alzheimer s Disease Reports. https://doi.org/10.1177/25424823261433532
Vancouver
Du Y, Tam W, Chu M.-F, Wong SM, Lam KW, Tong T.-K, et al. Impact of anticoagulation on cognitive decline and clinical outcomes in patients with atrial fibrillation and dementia: A retrospective cohort study. Journal of Alzheimer s Disease Reports. 2026. doi:10.1177/25424823261433532. PMID: 41929963.
BibTeX
@article{du2026-41929963,
author = {Du, Yun and Tam, Weng‐Chio and Chu, Man-Fong and Wong, Sio Mui and Lam, Kuok Wun and Tong, Tat-Kuong and Wong, Mei-Hong and Chan, Chon-Hou and others},
title = {{Impact of anticoagulation on cognitive decline and clinical outcomes in patients with atrial fibrillation and dementia: A retrospective cohort study}},
journal = {Journal of Alzheimer s Disease Reports},
year = {2026},
doi = {10.1177/25424823261433532},
pmid = {41929963},
url = {https://doi.org/10.1177/25424823261433532}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results Anticoagulated patients were younger (82.8 versus 85.1 years, p = 0.01).
- Anticoagulation was associated with slower cognitive/functional decline, with medium effect sizes, ΔMMSE mean difference: 2.0 points (95% CI: −3.5 to −0.4; p = 0.048), ΔADL mean difference: 10.9 points (95% CI: −19.6 to −2.3; p = 0.02), ΔCDR-SB mean difference: −1.4 points (95% CI: 0.4 to 2.4; p < 0.01).
- Conclusions In this retrospective, confounder-adjusted study, anticoagulation was associated with slower cognitive/functional decline and lower hospitalization/mortality risk in AF and dementia patients.
Why it matters
In this retrospective study of 291 patients with atrial fibrillation and dementia, anticoagulation was associated with slower cognitive and functional decline and reduced hospitalization and mortality risk. Anticoagulated patients were younger than those not anticoagulated.
Study details
- Study designcohort study
- Participants291
- Effect sizeHR 0.60; HR 0.59
- Evidence strengthModerate
How this study scored 49/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Alzheimer s Disease Reports) |
| Journal's citation record | 0 / 4 | Journal of Alzheimer s Disease Reports: journal h-index 40 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 2 / 4 | 291 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 3 / 6 | Cited 4.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Iek Long Lo: h-index 8 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Hospital Conde S. Januário: institution h-index 44 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41929963) |
| Free to read | 2 / 2 | Free to read |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1177/25424823261433532
- PubMed: 41929963
- Original source →
- Free full text: Journal of Alzheimer s Disease Reports →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Cognitive tests and assessment from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.